TP53 and hepatocellular carcinoma: However, as our study was limited to hepatomas with TP53R249S overexpression, further evidence is needed to explore whether the tumor‐suppressive effects of RELA are dependent on this specific TP53R249S mutation or extend to other TP53 dysfunction mutations as well.